Dernières nouvelles pour Covalon Technologies (OTC:CVALF) Stock

Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes and save lives in the areas of infection management, wound care, and surgical procedures. The company generates its revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products are CovaClear, IV IV Clear, SurgiClear, and VALGuard.

COVALON TECHS LTD by Covalon Technologies Ltd.

Covalon Technologies Ltd

Press Releases

Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO

Covalon Announces Profitable Second Quarter Fiscal 2024 Results

Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference

Events

Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST

Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting

Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference

Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results

CVALF

TSXV:COV

Covalon Technologies

Comments

Covalon Technologies

Actualités

Dernières nouvelles pour Covalon Technologies (OTC:CVALF) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL